Related Experiment Video
Updated: Jul 11, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Actions of estrogen and estrogen receptors in nonclassical target tissues
1Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institute of Health, 111 Alexander Drive, Research Triangle Park, 27709 North Caroline, USA.
Abstract:
Hormonal effects on classical endocrine target organs such as the female reproductive tract, mammary gland, ovary, and neuroendocrine system have been thoroughly studied, with significant advancements in our understanding of estrogen actions and disease conditions from both cell culture as well as new experimental animal models. Knowledge of the highly appreciated effects of estrogen in nonclassical endocrine organ systems, arising from epidemiological and clinical findings in the cardiovascular, immune, GI tract, and liver, is only now becoming clarified from the development and use of knock-out or transgenic animal models for the study of both estrogen and ER activities. There are considerable epidemiological data showing that premenopausal females (Barrett-Connor 1997; Crabbe et al. 2003) have reduced risk for cardiovascular disease. However, a recent large clinical trial failed to show cardioprotection for postmenopausal females on estrogen-progestin replacement (Rossouw et al. 2002). In fact, the Women's Health Initiative Study showed increased cardiovascular risk for females taking an estrogen-progestin combination. These studies suggest that we need a better understanding of the mechanisms responsible for cardioprotection in females.
Insights
Estrogen
Area of Science:
- Endocrinology and molecular biology
- Cardiovascular research
- Reproductive health
Background:
- Estrogen's effects on reproductive organs are well-understood.
- Emerging research explores estrogen's impact on non-classical systems like the cardiovascular system.
- Epidemiological data suggest premenopausal women have lower cardiovascular disease risk.
Purpose of the Study:
- To clarify the mechanisms behind female cardioprotection.
- To investigate the role of estrogen in cardiovascular health.
- To reconcile conflicting findings on hormone replacement therapy and cardiovascular risk.
Main Methods:
- Utilizing knock-out and transgenic animal models.
- Analyzing epidemiological and clinical trial data.
- Studying estrogen and estrogen receptor (ER) activities.
Main Results:
- Premenopausal women exhibit reduced cardiovascular disease risk.
- Estrogen-progestin replacement therapy in postmenopausal women did not show cardioprotection.
- The Women's Health Initiative Study indicated increased cardiovascular risk with combined therapy.
Conclusions:
- Further research is needed to understand female cardioprotection mechanisms.
- The role of estrogen in cardiovascular health requires deeper investigation.
- Conflicting results highlight the complexity of hormone effects on the cardiovascular system.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Intracellular Hormone Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Internal Receptors
Endocrine Signaling

